Oncology
Bioinformatics
Precision medicine
Companion diagnostics
Omics
Technology and innovation
Insights
Opinion and Personal Narratives
Molecular Pathology
Voices in the Community
Breaking the Biomarker Bottlenecks: Part 2
Industry leaders from AstraZeneca, Leica Biosystems, and Danaher share their insights on AI’s power to democratize access to precision medicine
02/16/2026
Interview
6 min read
